Swiss pharmaceutical company Novartis envisions a world where access to healthcare is not a privilege but a fundamental human right, and this vision drives its global health initiatives.

Switzerland-based Novartis has one of the strongest and broadest portfolios of varied drugs that has enabled it to maintain its dominant position as a top pharma company over the years.

(Bloomberg) -- Novartis AG raised its forecast as sales of blockbuster medicines for heart disease and psoriasis outpaced expectations, giving the stock its biggest boost in nine months.